198 related articles for article (PubMed ID: 24045882)
1. Prevention and reversal of ketamine-induced schizophrenia related behavior by minocycline in mice: Possible involvement of antioxidant and nitrergic pathways.
Monte AS; de Souza GC; McIntyre RS; Soczynska JK; dos Santos JV; Cordeiro RC; Ribeiro BM; de Lucena DF; Vasconcelos SM; de Sousa FC; Carvalho AF; Macêdo DS
J Psychopharmacol; 2013 Nov; 27(11):1032-43. PubMed ID: 24045882
[TBL] [Abstract][Full Text] [Related]
2. Alpha-lipoic acid alone and combined with clozapine reverses schizophrenia-like symptoms induced by ketamine in mice: Participation of antioxidant, nitrergic and neurotrophic mechanisms.
Vasconcelos GS; Ximenes NC; de Sousa CN; Oliveira Tde Q; Lima LL; de Lucena DF; Gama CS; Macêdo D; Vasconcelos SM
Schizophr Res; 2015 Jul; 165(2-3):163-70. PubMed ID: 25937462
[TBL] [Abstract][Full Text] [Related]
3. Morin Attenuates Neurochemical Changes and Increased Oxidative/Nitrergic Stress in Brains of Mice Exposed to Ketamine: Prevention and Reversal of Schizophrenia-Like Symptoms.
Ben-Azu B; Aderibigbe AO; Eneni AO; Ajayi AM; Umukoro S; Iwalewa EO
Neurochem Res; 2018 Sep; 43(9):1745-1755. PubMed ID: 29956036
[TBL] [Abstract][Full Text] [Related]
4. Doxycycline prevents and reverses schizophrenic-like behaviors induced by ketamine in mice via modulation of oxidative, nitrergic and cholinergic pathways.
Ben-Azu B; Omogbiya IA; Aderibigbe AO; Umukoro S; Ajayi AM; Iwalewa EO
Brain Res Bull; 2018 May; 139():114-124. PubMed ID: 29425796
[TBL] [Abstract][Full Text] [Related]
5. Molecular mechanisms involved in the prevention and reversal of ketamine-induced schizophrenia-like behavior by rutin: the role of glutamic acid decarboxylase isoform-67, cholinergic, Nox-2-oxidative stress pathways in mice.
Oshodi TO; Ben-Azu B; Ishola IO; Ajayi AM; Emokpae O; Umukoro S
Mol Biol Rep; 2021 Mar; 48(3):2335-2350. PubMed ID: 33811574
[TBL] [Abstract][Full Text] [Related]
6. Probable mechanisms involved in the antipsychotic-like activity of morin in mice.
Ben-Azu B; Aderibigbe AO; Omogbiya IA; Ajayi AM; Owoeye O; Olonode ET; Iwalewa EO
Biomed Pharmacother; 2018 Sep; 105():1079-1090. PubMed ID: 30021344
[TBL] [Abstract][Full Text] [Related]
7. Prevention and reversal of ketamine-induced experimental psychosis in mice by the neuroactive flavonoid, hesperidin: The role of oxidative and cholinergic mechanisms.
Ishola IO; Ben-Azu B; Adebayo OA; Ajayi AM; Omorodion IL; Edje KE; Adeyemi OO
Brain Res Bull; 2021 Dec; 177():239-251. PubMed ID: 34653559
[TBL] [Abstract][Full Text] [Related]
8. Involvement of GABAergic, BDNF and Nox-2 mechanisms in the prevention and reversal of ketamine-induced schizophrenia-like behavior by morin in mice.
Ben-Azu B; Aderibigbe AO; Ajayi AM; Eneni AO; Umukoro S; Iwalewa EO
Brain Res Bull; 2018 May; 139():292-306. PubMed ID: 29548911
[TBL] [Abstract][Full Text] [Related]
9. Reversal of schizophrenia-like symptoms and immune alterations in mice by immunomodulatory drugs.
da Silva Araújo T; Maia Chaves Filho AJ; Monte AS; Isabelle de Góis Queiroz A; Cordeiro RC; de Jesus Souza Machado M; de Freitas Lima R; Freitas de Lucena D; Maes M; Macêdo D
J Psychiatr Res; 2017 Jan; 84():49-58. PubMed ID: 27697587
[TBL] [Abstract][Full Text] [Related]
10. Neuronal injury, but not microglia activation, is associated with ketamine-induced experimental schizophrenic model in mice.
Hou Y; Zhang H; Xie G; Cao X; Zhao Y; Liu Y; Mao Z; Yang J; Wu C
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():107-16. PubMed ID: 23603358
[TBL] [Abstract][Full Text] [Related]
11. Neuroprotective effects of the ethanol stem bark extracts of Terminalia ivorensis in ketamine-induced schizophrenia-like behaviors and oxidative damage in mice.
Ben-Azu B; Aderibigbe AO; Ajayi AM; Iwalewa EO
Pharm Biol; 2016 Dec; 54(12):2871-2879. PubMed ID: 27250524
[TBL] [Abstract][Full Text] [Related]
12. Advantages of the Alpha-lipoic Acid Association with Chlorpromazine in a Model of Schizophrenia Induced by Ketamine in Rats: Behavioral and Oxidative Stress evidences.
Sampaio LRL; Cysne Filho FMS; de Almeida JC; Diniz DDS; Patrocínio CFV; de Sousa CNS; Patrocínio MCA; Macêdo D; Vasconcelos SMM
Neuroscience; 2018 Mar; 373():72-81. PubMed ID: 29337238
[TBL] [Abstract][Full Text] [Related]
13. Omega-3 prevents behavior response and brain oxidative damage in the ketamine model of schizophrenia.
Zugno AI; Chipindo HL; Volpato AM; Budni J; Steckert AV; de Oliveira MB; Heylmann AS; da Rosa Silveira F; Mastella GA; Maravai SG; Wessler PG; Binatti AR; Panizzutti B; Schuck PF; Quevedo J; Gama CS
Neuroscience; 2014 Feb; 259():223-31. PubMed ID: 24316471
[TBL] [Abstract][Full Text] [Related]
14. Effects of clozapine and risperidone antipsychotic drugs on the expression of CACNA1C and behavioral changes in rat 'Ketamine model of schizophrenia.
Azimi Sanavi M; Ghazvini H; Zargari M; Ghalehnoei H; Hosseini-Khah Z
Neurosci Lett; 2022 Jan; 770():136354. PubMed ID: 34801642
[TBL] [Abstract][Full Text] [Related]
15. Reversal and Preventive Pleiotropic Mechanisms Involved in the Antipsychotic-Like Effect of Taurine, an Essential β-Amino Acid in Ketamine-Induced Experimental Schizophrenia in Mice.
Ben-Azu B; Uruaka CI; Ajayi AM; Jarikre TA; Nwangwa KE; Chilaka KC; Chijioke BS; Omonyeme MG; Ozege CB; Ofili EC; Warekoromor EB; Edigbue NL; Esiekpe UV; Akaenyi DE; Agu GO
Neurochem Res; 2023 Mar; 48(3):816-829. PubMed ID: 36350433
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of ketamine-induced hyperlocomotion in mice by the essential oil of Alpinia zerumbet: possible involvement of an antioxidant effect.
de Araújo FY; de Oliveira GV; Gomes PX; Soares MA; Silva MI; Carvalho AF; de Moraes MO; de Moraes ME; Vasconcelos SM; Viana GS; de Sousa FC; Macêdo DS
J Pharm Pharmacol; 2011 Aug; 63(8):1103-10. PubMed ID: 21718294
[TBL] [Abstract][Full Text] [Related]
17. Naringin Confers Protection against Psychosocial Defeat Stress-Induced Neurobehavioral Deficits in Mice: Involvement of Glutamic Acid Decarboxylase Isoform-67, Oxido-Nitrergic Stress, and Neuroinflammatory Mechanisms.
Oladapo OM; Ben-Azu B; Ajayi AM; Emokpae O; Eneni AO; Omogbiya IA; Iwalewa EO
J Mol Neurosci; 2021 Mar; 71(3):431-445. PubMed ID: 32767187
[TBL] [Abstract][Full Text] [Related]
18. Sex influences in the preventive effects of peripubertal supplementation with N-3 polyunsaturated fatty acids in mice exposed to the two-hit model of schizophrenia.
da Costa AEM; Gomes NS; Gadelha Filho CVJ; Linhares MGOES; da Costa RO; Chaves Filho AJM; Cordeiro RC; Vasconcelos GS; da Silva FER; Araujo TDS; Vasconcelos SMM; Lucena DF; Macêdo DS
Eur J Pharmacol; 2021 Apr; 897():173949. PubMed ID: 33607108
[TBL] [Abstract][Full Text] [Related]
19. Antipsychotic effect of diosgenin in ketamine-induced murine model of schizophrenia: Involvement of oxidative stress and cholinergic transmission.
Ben-Azu B; Adebayo OG; Fokoua AR; Oritsemuelebi B; Chidebe EO; Nwogueze CB; Kumanwee L; Uyere GE; Emuakpeje MT
IBRO Neurosci Rep; 2024 Jun; 16():86-97. PubMed ID: 38282757
[TBL] [Abstract][Full Text] [Related]
20. Time course of the effects of lipopolysaccharide on prepulse inhibition and brain nitrite content in mice.
Custódio CS; Mello BS; Cordeiro RC; de Araújo FY; Chaves JH; Vasconcelos SM; Nobre Júnior HV; de Sousa FC; Vale ML; Carvalho AF; Macêdo DS
Eur J Pharmacol; 2013 Aug; 713(1-3):31-8. PubMed ID: 23665499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
